525 related articles for article (PubMed ID: 23090074)
1. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?
Klebanoff CA; Gattinoni L; Restifo NP
J Immunother; 2012; 35(9):651-60. PubMed ID: 23090074
[TBL] [Abstract][Full Text] [Related]
2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
3. Role of memory T cell subsets for adoptive immunotherapy.
Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
[TBL] [Abstract][Full Text] [Related]
4. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
Hinrichs CS; Borman ZA; Gattinoni L; Yu Z; Burns WR; Huang J; Klebanoff CA; Johnson LA; Kerkar SP; Yang S; Muranski P; Palmer DC; Scott CD; Morgan RA; Robbins PF; Rosenberg SA; Restifo NP
Blood; 2011 Jan; 117(3):808-14. PubMed ID: 20971955
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Diverse Progenies of Memory T Cells from Naïve CD8
Zanon V; Lugli E
Methods Mol Biol; 2017; 1514():103-110. PubMed ID: 27787795
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection.
Qian C; Wang Y; Cai H; Laroye C; De Carvalho Bittencourt M; Clement L; Stoltz JF; Decot V; Reppel L; Bensoussan D
J Immunother; 2016 Jan; 39(1):27-35. PubMed ID: 26641259
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.
Urak R; Walter M; Lim L; Wong CW; Budde LE; Thomas S; Forman SJ; Wang X
J Immunother Cancer; 2017; 5():26. PubMed ID: 28331616
[TBL] [Abstract][Full Text] [Related]
8. TGFβ Programs Central Memory Differentiation in
Dahmani A; Janelle V; Carli C; Richaud M; Lamarche C; Khalili M; Goupil M; Bezverbnaya K; Bramson JL; Delisle JS
Cancer Immunol Res; 2019 Sep; 7(9):1426-1439. PubMed ID: 31308016
[TBL] [Abstract][Full Text] [Related]
9. The who's who of T-cell differentiation: human memory T-cell subsets.
Mahnke YD; Brodie TM; Sallusto F; Roederer M; Lugli E
Eur J Immunol; 2013 Nov; 43(11):2797-809. PubMed ID: 24258910
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.
Crompton JG; Sukumar M; Restifo NP
Immunol Rev; 2014 Jan; 257(1):264-276. PubMed ID: 24329803
[TBL] [Abstract][Full Text] [Related]
11. Chimeric antigen receptor T cell persistence and memory cell formation.
McLellan AD; Ali Hosseini Rad SM
Immunol Cell Biol; 2019 Aug; 97(7):664-674. PubMed ID: 31009109
[TBL] [Abstract][Full Text] [Related]
12. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
Bachmann MF; Wolint P; Schwarz K; Jäger P; Oxenius A
J Immunol; 2005 Oct; 175(7):4686-96. PubMed ID: 16177116
[TBL] [Abstract][Full Text] [Related]
13. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.
Klebanoff CA; Scott CD; Leonardi AJ; Yamamoto TN; Cruz AC; Ouyang C; Ramaswamy M; Roychoudhuri R; Ji Y; Eil RL; Sukumar M; Crompton JG; Palmer DC; Borman ZA; Clever D; Thomas SK; Patel S; Yu Z; Muranski P; Liu H; Wang E; Marincola FM; Gros A; Gattinoni L; Rosenberg SA; Siegel RM; Restifo NP
J Clin Invest; 2016 Jan; 126(1):318-34. PubMed ID: 26657860
[TBL] [Abstract][Full Text] [Related]
14. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
Hinrichs CS; Borman ZA; Cassard L; Gattinoni L; Spolski R; Yu Z; Sanchez-Perez L; Muranski P; Kern SJ; Logun C; Palmer DC; Ji Y; Reger RN; Leonard WJ; Danner RL; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17469-74. PubMed ID: 19805141
[TBL] [Abstract][Full Text] [Related]
15. Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets.
Stemberger C; Neuenhahn M; Gebhardt FE; Schiemann M; Buchholz VR; Busch DH
Semin Immunol; 2009 Apr; 21(2):62-8. PubMed ID: 19269852
[TBL] [Abstract][Full Text] [Related]
16. Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.
Kondo T; Imura Y; Chikuma S; Hibino S; Omata-Mise S; Ando M; Akanuma T; Iizuka M; Sakai R; Morita R; Yoshimura A
Cancer Sci; 2018 Jul; 109(7):2130-2140. PubMed ID: 29790621
[TBL] [Abstract][Full Text] [Related]
17. In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.
Yang S; Gattinoni L; Liu F; Ji Y; Yu Z; Restifo NP; Rosenberg SA; Morgan RA
Cancer Immunol Immunother; 2011 May; 60(5):739-49. PubMed ID: 21305379
[TBL] [Abstract][Full Text] [Related]
18. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
Hinrichs CS; Spolski R; Paulos CM; Gattinoni L; Kerstann KW; Palmer DC; Klebanoff CA; Rosenberg SA; Leonard WJ; Restifo NP
Blood; 2008 Jun; 111(11):5326-33. PubMed ID: 18276844
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
20. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy.
Wang LX; Kjaergaard J; Cohen PA; Shu S; Plautz GE
J Immunol; 2004 Mar; 172(6):3462-8. PubMed ID: 15004146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
